Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences

The American Journal of the Medical Sciences
Antonio Anzueto

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD)-acute worsenings of dyspnea, cough and/or sputum production beyond daily symptom variations, necessitating a change in treatment-account for most COPD-related morbidity, care burden and direct costs. Frequent exacerbations (especially those requiring emergency, inpatient or intensive care) reduce physical activity, accelerate lung function decline and increase mortality. This review profiles exacerbation diagnosis, treatment and reduction measures for primary care physicians. Chronic maintenance pharmacotherapy is important to reduce exacerbations. Tiotropium, a long-acting anticholinergic, and salmeterol/fluticasone, a long-acting β-agonist/inhaled corticosteroid combination, are Food and Drug Administration-approved maintenance therapies to reduce exacerbations of COPD. Influenza and pneumonia vaccinations reduce infectious triggers; pulmonary rehabilitation reduces exacerbation recurrence. Acute exacerbation treatment (short-acting bronchodilators, systemic corticosteroids and/or antibiotics) should be complemented by long-term COPD maintenance therapy to reduce future exacerbations. Recognition of a COPD exacerbation signals primary care physicians to establish l...Continue Reading

References

Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·W H ThompsonJ J Crowley
Apr 20, 1999·Chest·D A MahlerW H Anderson
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
Jun 10, 2000·Chest·R Rodriguez-Roisin
Feb 28, 2002·The European Respiratory Journal·R CasaburiT Witek
Apr 12, 2002·Chest·Andrea RossiUNKNOWN Formoterol in Chronic Obstructive Pulmonary Disease (FICOPD) II Study Group
Mar 22, 2003·Respiratory Medicine·M T HalpernR Borker
Jun 27, 2003·The New England Journal of Medicine·Shawn D AaronGeorge Wells
Jun 5, 2004·The European Respiratory Journal·S SpencerP W Jones
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Dec 7, 2005·Respiration; International Review of Thoracic Diseases·David G TinkelmanConstant P van Schayck
Jan 31, 2006·Thorax·G C Donaldson, J A Wedzicha
Feb 2, 2006·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·David G TinkelmanR J Halbert
Mar 2, 2006·The European Respiratory Journal·D DusserP Iacono
Oct 27, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·John F O'ReillyLeanne Rice
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
May 17, 2007·The European Respiratory Journal·D J PowrieJ A Wedzicha
Jun 2, 2007·The European Respiratory Journal·B R Celli, P J Barnes
Sep 20, 2007·Proceedings of the American Thoracic Society·Antonio AnzuetoFernando J Martinez
Oct 6, 2007·American Journal of Respiratory and Critical Care Medicine·Jadwiga A WedzichaUNKNOWN INSPIRE Investigators
Dec 1, 2007·American Journal of Respiratory and Critical Care Medicine·Lisa LangsetmoJean Bourbeau
Jan 2, 2008·The European Respiratory Journal·E DeromM Decramer
Jan 19, 2008·American Journal of Respiratory and Critical Care Medicine·Timothy F MurphySanjay Sethi
Jan 29, 2008·Respiratory Medicine·Julia A WaltersRichard Wood-Baker
Apr 17, 2008·COPD·Fernando J MartinezUNKNOWN COPD-PS Clinician Working Group
Aug 9, 2008·Respiratory Medicine·Marc DecramerThierry Troosters
Aug 6, 2008·Annals of Internal Medicine·Andrew P WilperDavid U Himmelstein

❮ Previous
Next ❯

Citations

Oct 12, 2013·Family Practice·Salwan Al-aniHasse Melbye
Dec 14, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Len Fromer
Apr 23, 2011·The American Journal of the Medical Sciences·Stuart W Stoloff
Jul 23, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Han-Chung HuKuo-Chin Kao
Apr 10, 2014·Journal of Cancer Survivorship : Research and Practice·Heather P TarletonMarta Induni
Jun 27, 2013·Journal of Primary Care & Community Health·Barbara P Yawn
Sep 24, 2010·Postgraduate Medicine·Len FromerBarbara Yawn
Feb 23, 2012·Journal of Cardiopulmonary Rehabilitation and Prevention·Uta OchmannDennis Nowak
Apr 28, 2017·Tijdschrift voor gerontologie en geriatrie·Stephanie BlindenbachElizabeth M Wattel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.